Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients
Open Access
- 1 July 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (1) , 198-205
- https://doi.org/10.1038/bjc.1995.303
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Radiosensitivity, blood perfusion and tumour oxygenation after perflubron emulsion injectionRadiotherapy and Oncology, 1993
- Mechanism of action of the selective tumor radiosensitizer nicotinamideInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Hypoxia in Tumors: A Paradigm for the Approach to Biochemical and Physiologic HeterogeneityJNCI Journal of the National Cancer Institute, 1988
- Radiosensitization by Nicotinamide in Vivo: A Greater Enhancement of Tumor Damage Compared to That of Normal TissuesRadiation Research, 1987
- Chemical sensitizers for hypoxic cells: A decade of experience in clinical radiotherapyRadiotherapy and Oncology, 1985
- Does hyperbaric oxygen have a future in radiation therapy?International Journal of Radiation Oncology*Biology*Physics, 1981
- Determination of nicotinamide in human plasma and urine by ion-pair reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Carbogen breathing during radiation therapy The radiation therapy oncology group studyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcomaInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Clinical trial with atmospheric oxygen breathing during radiotherapy of cancer of the cervix.1968